TNF receptor 1 (TNFR1) can trigger opposing responses within the same cell: a prosurvival response or a cell-death pathway [1, 2] . Cell survival requires NF-kB-mediated transcription of prosurvival genes [3] [4] [5] [6] [7] [8] [9] ; apoptosis occurs if NF-kB signaling is blocked [5, [7] [8] [9] . Hence, activation of NF-kB acts as a cell-death switch during TNF signaling. This study demonstrates that the pathway includes another cell-death switch that is independent of NF-kB. We show that lysine 63-linked ubiquitination of RIP1 on lysine 377 inhibits TNF-induced apoptosis first through an NF-kB-independent mechanism and, subsequently, through an NF-kB-dependent mechanism. In contrast, in the absence of ubiquitination, RIP1 serves as a proapoptotic signaling molecule by engaging CASPASE-8. Therefore, RIP1 is a dual-function molecule that can be either prosurvival or prodeath depending on its ubiquitination state, and this serves as an NF-kB-independent cell-death switch early in TNF signaling. These results provide an explanation for the conflicting reports on the role of RIP1 in cell death; this role was previously suggested to be both prosurvival and prodeath [10] [11] [12] . Because TRAF2 is the E3 ligase for RIP1 [13] , these observations provide an explanation for the NF-kB-independent antiapoptotic function previously described for TRAF2 [14] [15] [16] .
Summary TNF receptor 1 (TNFR1) can trigger opposing responses within the same cell: a prosurvival response or a cell-death pathway [1, 2] . Cell survival requires NF-kB-mediated transcription of prosurvival genes [3] [4] [5] [6] [7] [8] [9] ; apoptosis occurs if NF-kB signaling is blocked [5, [7] [8] [9] . Hence, activation of NF-kB acts as a cell-death switch during TNF signaling. This study demonstrates that the pathway includes another cell-death switch that is independent of NF-kB. We show that lysine 63-linked ubiquitination of RIP1 on lysine 377 inhibits TNF-induced apoptosis first through an NF-kB-independent mechanism and, subsequently, through an NF-kB-dependent mechanism. In contrast, in the absence of ubiquitination, RIP1 serves as a proapoptotic signaling molecule by engaging CASPASE-8. Therefore, RIP1 is a dual-function molecule that can be either prosurvival or prodeath depending on its ubiquitination state, and this serves as an NF-kB-independent cell-death switch early in TNF signaling. These results provide an explanation for the conflicting reports on the role of RIP1 in cell death; this role was previously suggested to be both prosurvival and prodeath [10] [11] [12] . Because TRAF2 is the E3 ligase for RIP1 [13] , these observations provide an explanation for the NF-kB-independent antiapoptotic function previously described for TRAF2 [14] [15] [16] .
Results and Discussion
TNFR1 ligation can induce the prosurvival NF-kB pathway or the cell-death pathway. The molecular mechanism that determines which of these two opposing signaling pathways is triggered is unclear. Lysine 377 of RIP1 was recently shown to be an acceptor site for K63-linked polyubiquitination, and this mediates efficient NF-kB activation by TNF ( [17, 18] and Figure S1 in the Supplemental Data available online). Whether ubiquitination of lysine 377 regulates the opposing cell-death pathway has not been fully examined. To do so, we quantified TNF-induced apoptosis in RIP1-null Jurkat cells or RIP1-null cells reconstituted with RIP1-WT or RIP1-K377R. After 5 hr of TNF treatment, there was no significant difference in the amount of apoptosis of RIP1-null or RIP1-WT cells ( Figure 1A and Figure S1D ). This comparison did not reveal a role for RIP1 in apoptosis. However, a comparison of the RIP1-K377R cells to the RIP1-WT cells showed a clear enhancement in sensitivity to TNF-mediated killing in RIP1-K377R cells, suggesting that ubiquitination of RIP1 serves to inhibit apoptosis. The surprising observation was that RIP1-K377R cells are more sensitive to apoptosis even though they activate more NF-kB than RIP1-null cells (Figures S1A and S1B). This suggests that ubiquitination of lysine 377 at this early time point has an antiapoptotic effect that may be independent of NF-kB because there is no correlation between induction of NF-kB signaling and sensitivity to apoptosis. After 24 hr of TNF stimulation, the RIP1-K377R cells remained more susceptible to TNFmediated killing than RIP1-null cells. However, the RIP1-WT cells were then less susceptible than RIP1-null cells, suggesting that upon prolonged stimulation, RIP1-WT provides an additional antiapoptotic signal ( Figure 1A) . A time-course experiment showed that RIP1-K377R cells have a discernable enhancement in sensitivity to apoptosis in comparison to either RIP1-null or RIP1-WT cells by 4 hr, and this enhancement persisted for the duration of the experiment ( Figure 1B ). The resistance of the RIP1-WT cells to apoptosis in comparison to RIP1-null cells was not apparent during the first 12 hr but is discernable after 24 hr. Thus, ubiquitination of RIP1 on lysine 377 appears to provide at least two distinct survival signals: one that is apparent after a short period of receptor ligation and a second one that is evident only after prolonged stimulation.
TNF-mediated apoptosis requires CASPASE-8, which initiates cleavage and activation of the executioner caspase, CASPASE-3, to cleave substrates including poly (ADP Ribose) polymerase (PARP). RIP1-K377R cells exhibit faster CASPASE-8 processing to the active p18 fragment and enhanced CASPASE-3 and PARP cleavage in comparison to RIP1-WT cells ( Figure 1C , left panel). Consistent with the time-course experiment, more CASPASE-8, -3, and PARP cleavage were observed in response to increasing concentrations of TNF in the RIP1-K377R cells ( Figure 1C, right panel) . Therefore, the enhanced apoptosis observed in RIP1-K377R cells compared to RIP1-WT cells ( Figure 1A ) is due to increased activation of caspases upon TNFR1 ligation.
We next hypothesized that NF-kB activation is not required for the early prosurvival signal mediated by RIP1's ubiquitination but that the second prosurvival signal is dependent on NF-kB transcription factors. We tested these hypotheses by blocking NF-kB activation in RIP1-null, RIP1-WT, and RIP1-K377R cells by stable transfection of the IkBaSR ( Figure S2 ). NF-kB blockade had no effect on the sensitivity of the three different cell lines to apoptosis after a short TNF stimulation of 5 hr; the RIP1-K377R cells remained more sensitive to *Correspondence: adrian.ting@mssm.edu apoptosis than the RIP1-null and RIP1-WT cells in the presence of the IkBaSR (Figure 2A , panels I and II and Figure S2C ). Therefore, we conclude that the enhanced sensitivity in the RIP1-K377R cells is not due to its reduced capacity to activate the NF-kB signaling pathway. Rather, this reflects the loss of an NF-kB-independent antiapoptotic signal in the RIP1-K377R cells; this loss is consistent with the hypothesis that ubiquitination of RIP1 provides an NF-kB-independent antiapoptotic signal early in TNFR1 signaling. Next, we analyzed the effect of NF-kB blockade after a prolonged 24 hr stimulation with TNF. In the presence of the IkBaSR, both the RIP1-null and RIP1-WT cells were equally sensitive to TNF-mediated apoptosis ( Figure 2A , panel IV and Figure S2C), confirming that the second, delayed antiapoptotic effect of RIP1-WT is dependent on NF-kB signaling. Moreover, the continued heightened sensitivity of the RIP1-K337R cells to apoptosis after extended TNF stimulation indicates the NF-kB independence of the early antiapoptotic effect of RIP1 ubiquitination.
We performed a time-course experiment to determine the kinetic relationship of the two antiapoptosis signals ( Figure 2B ). In both the control and the IkBaSR-transfected cells, we consistently observed enhanced apoptosis in the RIP1-K377R cells as of 4 hr after stimulation, indicating that the initial NF-kB-independent antiapoptotic signal was having an effect by that time. Consistent with the time-course experiment in Figure 1B , the sensitivity of the RIP1-WT and RIP1-null cells only showed a difference after 24 hr ( Figure 2B, panel I ). This prosurvival effect of RIP1-WT was abrogated in the presence of IkBaSR ( Figure 2B, panel II) . Thus, the NF-kB-dependent antiapoptotic signal generated by RIP1 comes into effect only after prolonged stimulation. This kinetic analysis confirms that ubiquitination of RIP1 on lysine 377 provides first an antideath signal that is independent of NF-kB, and this signal is then followed by one that is dependent on NF-kB. To gain insight into whether the NF-kB-independent antiapoptotic signal inhibits caspases, we compared CASPASE-8, -3, and PARP cleavage in the RIP1-WT and RIP1-K377R cells transfected with the IkBaSR. The RIP1-K377R/IkBaSR cells showed enhanced cleavage in a time-and dose-dependent manner ( Figure 2C) . Therefore, the NF-kB-independent, antiapoptosis signal provided by ubiquitination of lysine 377 of RIP1 inhibits the activation of CASPASE-8.
Loss-of-function of TRAF2 (the E3 ligase for RIP1 [13] ) or its upstream E2 ubiquitin-conjugating enzyme UBC13 [19] should result in the same phenotype, i.e., enhanced apoptosis in an NF-kB-independent manner, as the loss of the K377 ubiquitin acceptor site. The IKKg-deficient Jurkat T cell line 8321, which lacks NF-kB signaling [20] , was transduced with a dominant-negative mutant of TRAF2 (TRAF2DN) or UBC13 (UBC13DN). As predicted, the TRAF2DN-and UBC13DN-expressing cells are both more sensitive to apoptosis than control cells after either 5 or 24 hr of TNF treatment ( Figure 3A ). In agreement with this, more activation of the caspase cascade was observed in the TRAF2DN and UBC13DN cells compared to the negative control in a dose-dependent ( Figure S3A ) and time-dependent manner ( Figure 3B) . Consistent with published studies [14] [15] [16] , Traf2
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MEFs also exhibited similar NF-kB-independent enhancements in apoptosis ( Figure S4 ). We conclude that K63-linked ubiquitination of RIP1 by UBC13 and TRAF2 provides an NF-kB-independent antiapoptotic signal. Conversely, the loss of K63-linked ubiquitination, either through blockade of the E2 and E3 ligase or through the loss of the ubiquitin acceptor site on RIP1, generates a prodeath signal.
The observations up to this point suggest that TRAF2 loss-of-function enhances apoptosis because RIP1 becomes a death-signaling molecule in the absence of ubiquitination. If so, TRAF2 loss-of-function should have less of an effect in RIP1-null cells than in RIP1-sufficient cells. We expressed the TRAF2DN in both the RIP1-null and RIP1-WT cell lines. After either 5 or 24 hr of stimulation, the RIP1-null/TRAF2DN cells clearly displayed lower sensitivity to apoptosis than the RIP1-WT/TRAF2DN cells ( Figure 3C ). Therefore, TRAF2 lossof-function potentiates cell death in a RIP1-dependent manner. The 24 hr experiment further highlights the dual functionality of RIP1. In control-transfected cells, the presence of RIP1 confers protection against apoptosis, whereas in TRAF2DN-transfected cells, the presence of RIP1 confers sensitivity to apoptosis ( Figure 3D) .
Lastly, we hypothesized that ubiquitination of RIP1 or the lack thereof may regulate its interaction with CASPASE-8 because of a report showing a direct interaction between the PRO domain of CASPASE-8 and RIP1 [21] . Furthermore, CASPASE-8 can cleave RIP1, and this finding is also suggestive of a direct interaction [22] [23] [24] . We carried out coimmunoprecipitation studies to test this hypothesis. In RIP1-WT cells, a low level of RIP1-PROCASPASE-8 interaction was observed, and this was not altered upon TNF stimulation. In contrast, there is a stimulus-dependent association of PROCAS-PASE-8, as well as processed CASPASE-8, with RIP1 in the RIP1-K377R cells ( Figure 4A ). Therefore, ubiquitination of RIP1 prevents RIP1 from forming a complex with CASPASE-8. Conversely, in the absence of ubiquitination, RIP1 is able to form a complex with CASPASE-8 to initiate apoptosis.
The observations presented here indicate that RIP1 is a dual-functional signaling molecule that is capable of either prosurvival or prodeath signaling depending on its ubiquitination state. We propose a model in which RIP1, ubiquitinated by TRAF2 on lysine 377, provides two distinct antiapoptotic signals ( Figure 4B ). The first antiapoptotic signal occurs early after receptor ligation to prevent RIP1 from complexing with CASPASE-8 and is not dependent on the NF-kB pathway. The second antiapoptotic signal emerges at a later time point, and it is dependent on NF-kB-mediated upregulation of antiapoptotic genes such as c-FLIP. In the absence of ubiquitination, RIP1 converts to a death-signaling molecule that actively engages CASPASE-8 independently of its effect on NF-kB signaling. Because ubiquitination of RIP1 occurs prior to the induction of NF-kB-mediated gene transcription and can regulate cell death in an NF-kB-independent manner, we propose that the ubiquitination status of lysine 377 is a cell-death decision switch early in TNF signaling.
The role of RIP1 in TNF-mediated apoptosis has been controversial, with reports of either prosurvival or prodeath effects [10] [11] [12] . Our observation that RIP1 can generate either prosurvival or prodeath signals depending on the ubiquitination state of lysine 377 provides an explanation for these conflicting reports. It is also well appreciated that TRAF2 has an NF-kB-independent antiapoptotic function [14] [15] [16] 25] , but the underlying mechanism has been unclear. Our results now suggest that the antiapoptotic function of TRAF2 is due in part to its ubiquitination of RIP1, which acts as a brake on the prodeath effect of RIP1. The results described here raise the possibility that altering the ubiquitination state of RIP1 will influence cell survival, which can be achieved physiologically by altering the level of TRAF2 in the cell. In this regard, stimulation of TNFR2 is known to lead to TRAF2 degradation [12, 26, 27] and to potentiate TNFR1-mediated cell death in a RIP1-dependent manner [12, 28] . It is likely that in cells that express both TNFR1 and TNFR2, TRAF2 degradation triggered by TNFR2 creates a situation akin to the RIP1-K377R mutation, which then enables TNFR1 to engage the apoptotic cascade more efficiently via nonubiquitinated RIP1.
The observations in this study raise additional questions regarding the regulation of the RIP1-dependent apoptotic pathway. For instance, because only a fraction of the total pool of RIP1 in a wild-type cell is ubiquitinated in response to TNF, why isn't the nonubiquitinated pool of RIP1 interacting with CASPASE-8? Because these death-signaling molecules are constitutively expressed in cells, it is in the interest of the cell to prevent these interactions from occurring in unstimulated cells. These preventive mechanisms are poorly understood and could involve differential subcellular localization of the molecules, the requirement for posttranslational modifications or conformational changes for the interactions to occur, or the presence of inhibitors bound to RIP1 and CASPASE-8. In the case of RIP1, it is likely that only a fraction of the total RIP1 is released from inhibition to become active, whereas the rest of the pool remains in an inactive state and does not interact with CASPASE-8. It has been shown that RIP1 is recruited to TNFR1 in both
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+/+ and Traf2 2/2 cells [29] , suggesting that ubiquitination is not required for this process. The receptorassociated RIP1 may therefore constitute the active pool (A) RIP1-WT and RIP1-K377R cells were stimulated with 10 ng/ml TNF for the indicated times. FLAG-tagged RIP1 and associated proteins were immunoprecipitated with anti-FLAG beads and eluted with the FLAG peptide. The immune complexes were blotted sequentially with anti-CASPASE-8 and anti-RIP1 as a loading control. The anti-CASPASE-8 blot was also overexposed so that the p43/p41 cleaved form could be visualized. of RIP1. The observation that RIP1-WT fails to form a complex with CASPASE-8 whereas RIP1-K377R is able to do so also raises the question as to how the ubiquitination status of RIP1 determines its association with CASPASE-8. One possibility is that RIP1 molecules recruited to the receptor are retained at the plasma membrane if they undergo ubiquitination via ubiquitin-dependent binding to molecules such as TAB2/3 and IKKg [17, 18, 30] . In the absence of ubiquitination, RIP1 molecules recruited to the receptor are not retained at the plasma membrane and may now translocate to the cytosolic compartment where CASPASE-8 is located. Alternatively, ubiquitination of RIP1 may block its interaction with CASPASE-8 via steric hindrance, either because of the polyubiquitin chains themselves or because binding of IKKg and TAB2/3 to the polyubiquitin chains prevents CASPASE-8 from binding. These possibilities are currently being investigated.
Although the initial antiapoptotic signal provided by ubiquitination of RIP1 does not require NF-kB signaling, it is likely that NF-kB-mediated gene transcription can modulate this ubiquitination event. For instance, NF-kB induces several ubiquitin-modifying proteins, including TRAF2, c-IAPs, A20, and CYLD [3, 31, 32] . Some of these molecules are known to interact with RIP1, and therefore the net amount of ubiquitination on lysine 377 is likely to be dependent on the levels and activity of these molecules. As we have shown in this report, the level of ubiquitination on this critical lysine residue in turn determines whether the net outcome is survival or death. 
